The store will not work correctly when cookies are disabled.
1-(3-(4-fluorophenoxy)propyl)-3-(4-methoxyphenyl)guanidine
ID: ALA4092687
PubChem CID: 72950535
Max Phase: Preclinical
Molecular Formula: C17H20FN3O2
Molecular Weight: 317.36
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(NC(=N)NCCCOc2ccc(F)cc2)cc1
Standard InChI: InChI=1S/C17H20FN3O2/c1-22-15-9-5-14(6-10-15)21-17(19)20-11-2-12-23-16-7-3-13(18)4-8-16/h3-10H,2,11-12H2,1H3,(H3,19,20,21)
Standard InChI Key: VAOKFJZCNXIHTK-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
42.0895 -7.0452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.7972 -6.6366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.3818 -6.6366 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.6785 -7.0462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.5049 -7.0452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.2126 -6.6366 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
44.9203 -7.0452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.9180 -7.8634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.6249 -8.2720 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.3336 -7.8633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
46.3309 -7.0419 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.6235 -6.6371 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
47.0418 -8.2710 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
39.9693 -6.6404 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.6817 -7.8634 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.2631 -7.0517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5568 -6.6434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8511 -7.0541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8539 -7.8721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5681 -8.2778 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.2709 -7.8648 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1483 -8.2844 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.4385 -7.8795 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 1 0
3 4 1 0
2 5 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
10 13 1 0
4 14 1 0
4 15 2 0
14 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 16 1 0
19 22 1 0
22 23 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 317.36 | Molecular Weight (Monoisotopic): 317.1540 | AlogP: 3.24 | #Rotatable Bonds: 7 |
Polar Surface Area: 66.37 | Molecular Species: BASE | HBA: 3 | HBD: 3 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 10.47 | CX LogP: 2.91 | CX LogD: 0.59 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.42 | Np Likeness Score: -0.99 |
References
1. Salvino JM, Srikanth YVV, Lou R, Oyer HM, Chen N, Kim FJ.. (2017) Novel small molecule guanidine Sigma1 inhibitors for advanced prostate cancer., 27 (10): [PMID:28385503] [10.1016/j.bmcl.2017.03.030] |